Identification of risk factors for the progression of age-related macular degeneration: a systematic review and meta-analysis of cohort studies
- PMID: 40771483
- PMCID: PMC12325228
- DOI: 10.3389/fmed.2025.1544765
Identification of risk factors for the progression of age-related macular degeneration: a systematic review and meta-analysis of cohort studies
Abstract
Background: Age-related macular degeneration (AMD) is a retinal degenerative disease that primarily affects the elderly population and is a leading cause of vision loss in older adults. There is a lack of research comprehensively examining the risk factors for AMD progression. This study aimed to identify the risk factors influencing the development of AMD using a meta-analysis approach.
Methods: We systematically searched the PubMed, Embase, and Cochrane Library databases from their inception until November 2024. Summary effect estimates were assigned as odds ratios (ORs) with 95% confidence intervals (CIs) using a random effects model. Further exploratory analyses included sensitivity and sub-group analyses.
Results: Eighteen cohort studies involving 38,697 individuals were included in the final meta-analysis. We noted male versus female was associated with a reduced risk of AMD (OR: 0.84; 95% CI: 0.72-0.98; p = 0.027). The identified risk factors for AMD included per 5-year increment in age (OR: 1.14; 95% CI: 1.09-1.19; p < 0.001), current smoking (OR: 1.28; 95% CI: 1.07-1.52; p = 0.007), alcohol intake (OR: 1.30; 95% CI: 1.00-1.67; p = 0.046), per 1 mmol/L increment in high-density lipoprotein (OR: 1.21; 95% CI: 1.08-1.36; p = 0.001), total drusen >10% of the grid (OR: 7.85; 95% CI: 4.66-13.23; p < 0.001), presence of depigmentation (OR: 6.39; 95% CI: 2.48-16.44; p < 0.001), presence of hyperpigmentation (OR: 6.03; 95% CI: 1.94-18.73; p = 0.002), and >10 small drusen (OR: 7.21; 95% CI: 2.10-24.72; p = 0.002).
Conclusion: This study systematically identified the risk factors for AMD progression, and exploratory analyses were performed to determine the risk factors for early and late AMD. Patients at high risk of AMD should be monitored to improve modifiable risk factors and slow the progression of AMD.
Systematic review registration: INPLASY platform (INPLASY2024120036).
Keywords: age-related macular degeneration; meta-analysis; progression; risk factors; systematic review.
Copyright © 2025 Tian and Zhang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures







Similar articles
-
Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration.Cochrane Database Syst Rev. 2024 Jun 3;6(6):CD015804. doi: 10.1002/14651858.CD015804.pub2. Cochrane Database Syst Rev. 2024. PMID: 38829176 Free PMC article.
-
Blue-light filtering intraocular lenses (IOLs) for protecting macular health.Cochrane Database Syst Rev. 2018 May 22;5(5):CD011977. doi: 10.1002/14651858.CD011977.pub2. Cochrane Database Syst Rev. 2018. PMID: 29786830 Free PMC article.
-
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.Cochrane Database Syst Rev. 2023 Sep 13;9(9):CD000254. doi: 10.1002/14651858.CD000254.pub5. Cochrane Database Syst Rev. 2023. PMID: 37702300 Free PMC article.
-
Artificial intelligence for diagnosing exudative age-related macular degeneration.Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015522. doi: 10.1002/14651858.CD015522.pub2. Cochrane Database Syst Rev. 2024. PMID: 39417312
-
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD000254. doi: 10.1002/14651858.CD000254.pub4. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2023 Sep 13;9:CD000254. doi: 10.1002/14651858.CD000254.pub5. PMID: 28756618 Free PMC article. Updated.
References
Publication types
LinkOut - more resources
Full Text Sources